Key facts
- This page summarizes Daniel E. Greenleaf's Form 4 filing for ModivCare Inc (MODV).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 10 Feb 2022, 20:09.
Daniel E. Greenleaf - 08 Feb 2022 Form 4 Insider Report for ModivCare Inc (MODV)
- Reporting relationship
- CEO and President, Director
- Issuer ticker
- MODV
- Reported as of
- 08 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Feb 2022, 20:09:21 UTC
- Prior SEC filing
- 17 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jonathan Bush by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Daniel E. Greenleaf filed Form 4 for ModivCare Inc (MODV) on 10 Feb 2022.
Change
- Previous filing in this sequence was filed on 17 Sep 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MODV
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +9,170
- Change %
- +26%
- Price
- $0.000000
- Shares after
- 44,248
- Date
- 08 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MODV
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +26,136
- Change %
- Price
- $0.000000
- Shares after
- 26,136
- Date
- 08 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 26,136
- Exercise price
- $110.07
- Footnotes
- F2
MODV
transaction
Derivative
Performance Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +18,340
- Change %
- Price
- $0.000000
- Shares after
- 18,340
- Date
- 08 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- Exercise price
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents restricted stock units scheduled to vest as follows: (1) 3,057 shares will vest on February 8, 2023, (2) 3,056 shares will vest on February 8, 2024 and (3) 3,057 shares will vest on February 8, 2025, in each case, subject to the reporting person's continued employment.
Footnote F2
Option becomes exercisable with respect to: (1) 8,712 shares on February 8, 2023, (2) 8,712 shares on February 8, 2024 and (3) 8,712 shares on February 8, 2025, in each case, subject to the reporting person's continued employment.
Footnote F3
Represents the contingent right to receive a number of shares of issuer common stock determined by multiplying the number of performance units by a percentage from 50% to 200% that corresponds to specified share price thresholds measured by reference to a volume-weighted average price (VWAP) of the issuer's common stock over a specified period of trading days prior to the expiration date of the award, subject to the reporting person's continued employment.